STORY
4
days
2
outlets
4
reports
running since
19.08
LATEST
Moderna (MRNA) Soars 179% as Melanoma Therapy Candidate Rewrites Growth Story
finance.yahoo.com · 23.08.2026 08:23
HOW IT DEVELOPED
Moderna Soars as Vaccine-Drug Combo Slows Recurrence of Melanoma
finance.yahoo.com
· 20.08 06:01
Moderna (MRNA)’s Melanoma Vaccine Win: Big Opportunity, Bigger Expectations
finance.yahoo.com
· 19.08 23:58
mRNA cancer vaccine succeeded in Phase 3 melanoma trial, Moderna and Merck say
arstechnica.com
· 19.08 18:53